Table 2 Between-species percent identities and similarities of CD18 constitutive blocks
Block | Wb vs. Po (%) | Wb vs. Bo (%) | Wb vs. Bu (%) | Wb vs. Cap (%) | Wb vs. OvAr (%) | Wb vs. OvCan (%) | Wb vs. Hu (%) | Wb vs. Can (%) | Wb vs. Mu (%) | Wb vs. Ra (%) | Wb vs. Gal (%) | Wb vs. Cyp (%) | Wb vs. Ict (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | 99%(1) 99%(2) | 88% 93% | 88% 93% | 88% 93% | 88% 93% | 87% 93% | 83% 90% | 81% 89% | 81% 88% | 80% 88% | 62% 76% | 49% 64% | 48% 63% |
Putative signal peptide | 100% 100% | 59% 68% | 54% 68% | 59% 68% | 59% 72% | 59% 72% | 56% 60% | 56% 60% | 52% 60% | 60% 60% | 28% 44% | 28% 32% | 22% 50% |
Extracellular domain | 99% 99% | 88% 94% | 89% 94% | 89% 94% | 88% 94% | 88% 93% | 84% 91% | 82% 91% | 81% 89% | 80% 88% | 63% 77% | 50% 64% | 48% 63% |
   PSI | 100% 100% | 84% 92% | 86% 94% | 88% 92% | 88% 92% | 86% 90% | 75% 88% | 88% 92% | 80% 90% | 78% 88% | 65% 78% | 55% 69% | 61% 75% |
   Spacer (Hybrid domain) | 100% 100% | 77% 91% | 79% 91% | 77% 93% | 77% 93% | 77% 93% | 89% 93% | 83% 93% | 79% 87% | 67% 79% | 38% 56% | 25% 42% | 30% 50% |
   I-like domain | 99% 100% | 96% 98% | 96% 98% | 95% 98% | 95% 98% | 95% 98% | 96% 98% | 95% 99% | 95% 97% | 95% 97% | 79% 89% | 65% 75% | 63% 75% |
MIDAS | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% |
ADMIDAS | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 66% 100% | 66% 100% | 66% 100% | 100% 100% | 100% 100% | 66% 66% |
LIMBS | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% | 100% 100% |
   Mid-region (Hybrid domain) | 100% 100% | 91% 96% | 91% 96% | 93% 96% | 93% 96% | 92% 95% | 92% 97% | 89% 95% | 84% 90% | 82% 90% | 58% 71% | 41% 53% | 32% 54% |
   EGF-1 | 97% 100% | 73% 91% | 70% 91% | 76% 94% | 73% 94% | 70% 91% | 67% 82% | 61% 79% | 70% 88% | 67% 85% | 35% 52% | 47% 64% | 30% 52% |
   EGF-2 | 100% 100% | 100% 100% | 100% 100% | 98% 100% | 98% 100% | 98% 100% | 88% 96% | 81% 94% | 88% 98% | 88% 98% | 79% 94% | 41% 58% | 41% 50% |
   EGF-3 | 97% 97% | 87% 94% | 87% 94% | 87% 92% | 82% 92% | 79% 92% | 76% 87% | 69% 87% | 66% 79% | 79% 84% | 64% 76% | 48% 66% | 51% 74% |
   EGF-4 | 100% 100% | 92% 94% | 92% 94% | 92% 92% | 92% 92% | 92% 92% | 69% 82% | 76% 92% | 66% 76% | 69% 79% | 61% 66% | 43% 58% | 38% 48% |
   β-tail domain | 100% 100% | 74% 81% | 74% 81% | 73% 80% | 73% 80% | 73% 80% | 57% 71% | 54% 65% | 56% 69% | 56% 70% | 42% 64% | 39% 52% | 39% 56% |
Transmembrane region | 95% 95% | 91% 95% | 91% 95% | 91% 95% | 95% 100% | 95% 100% | 78% 91% | 82% 91% | 73% 91% | 69% 91% | 56% 73% | 52% 78% | 52% 78% |
Cytoplasmic tail | 100% 100% | 93% 93% | 93% 93% | 93% 93% | 93% 93% | 93% 93% | 91% 93% | 89% 95% | 91% 95% | 89% 93% | 65% 82% | 50% 68% | 50% 68% |
   Cytohesin, Rack1 binding site | 100% 100% | 75% 75% | 75% 75% | 75% 75% | 75% 75% | 75% 75% | 50% 50% | 75% 75% | 75% 75% | 75% 75% | 50% 100% | 25% 50% | 50% 50% |
   α-actinin binding site | 100% 100% | 90% 90% | 90% 90% | 90% 90% | 90% 90% | 90% 90% | 90% 100% | 90% 100% | 90% 100% | 90% 100% | 63% 90% | 45% 72% | 54% 72% |